Drawing for LYTOS

USPTO serial 99437059

LYTOS

Reviewed by CopyMark Law Group

Filing date
Status date
Registration date
—
Examiner
CANFIELD III, JOSEPH J
Law office
PUBLICATION AND ISSUE SECTION

What this means

Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance. Monitor the opposition window. After it closes, watch for Notice of Allowance (intent-to-use) or registration (use-based).

Status 686: Status 686 means your mark is published in the USPTO Official Gazette and in the 30-day opposition period. If no opposition is filed, prosecution typically continues toward registration or a Notice of Allowance.

Need help with LYTOS?

If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.

Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.

Owner

Attorney of record

The USPTO lists this attorney as the applicant's representative for correspondence on this application.

James F Keenan

Bernstein Shur100 Middle StreetPortland, ME 04104

Goods and services

ClassDescriptionStatusFirst use
010Medical device, namely, biodegradable embolic microspheres for transarterial embolization; Medical device, namely, biodegradable embolic microspheres for vascular embolization; Medical device, namely, degradable embolic microspheres for direct puncture embolization; Medical device, namely, biodegradable embolic microspheres for the treatment of tendinopathy; Medical device, namely, biodegradable embolic microspheres for the treatment of plantar fasciitis; Medical device, namely, biodegradable embolic microspheres for the treatment of Achilles tendinitis; Medical device, namely, resorbable embolic microspheres for transarterial embolization; Medical device, namely, resorbable embolic microspheres for vascular embolization; Medical device, namely, resorbable embolic microspheres for direct puncture embolization; Medical device, namely, resorbable embolic microspheres for the treatment of tendinopathy; Medical device, namely, resorbable embolic microspheres for the treatment of plantar fasciitis; Medical device, namely, resorbable embolic microspheres for the treatment of Achilles tendinitisACTIVE—

Related trademarks

CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.

Prosecution history

DateCodeEventWhat it means
Oct 13, 2026NPUBOFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED—
Oct 13, 2026PUBOPUBLISHED FOR OPPOSITIONYour mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance.
Oct 7, 2026NONPNOTIFICATION OF NOTICE OF PUBLICATION E-MAILED—
Sep 15, 2026CNSAAPPROVED FOR PUB - PRINCIPAL REGISTER—
Aug 16, 2026TEMETEAS/EMAIL CORRESPONDENCE ENTERED—
Aug 16, 2026CRFACORRESPONDENCE RECEIVED IN LAW OFFICE—
Aug 16, 2026ALIEASSIGNED TO LIE—
Aug 13, 2026ERSITEAS RESPONSE TO SUSPENSION INQUIRY RECEIVED—
Mar 7, 2026GNS3NOTIFICATION OF LETTER OF SUSPENSION E-MAILED—
Mar 7, 2026GNSLLETTER OF SUSPENSION E-MAILED—
Mar 7, 2026CNSLSUSPENSION LETTER WRITTEN—
Feb 27, 2026DOCKASSIGNED TO EXAMINER—
Feb 11, 2026NWOSNEW APPLICATION OFFICE SUPPLIED DATA ENTERED—
Oct 10, 2025MAFRAPPLICATION FILING RECEIPT MAILED—
Oct 10, 2025NWAPNEW APPLICATION ENTERED—

Frequently asked questions

Related guidance